Dover has entered into a definitive settlement to accumulate Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and management instruments for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
diaphragm seal will increase Dover’s biopharma single-use production offering, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in revenue through the full year 2022.
When the deal closes, Malema will turn into a part of the PSG business unit within Dover’s Pumps & Process Solutions section.
“We see an amazing long-term progress alternative in the bioprocessing industry driven by a robust and rising pipeline of efficient novel biologic medicine, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the growing adoption of extra environment friendly single-use manufacturing processes helps a robust outlook for our offerings of single-use components to end-customers. We believe that pairing Malema’s know-how with our current portfolio of single-use pumps for biopharma processing will greatly improve the accuracy and value proposition of our solutions to our prospects.”
“We are methodically building out our biopharma platform by way of proactive capability additions, new product development, and opportunistic acquisitions of highly-attractive niche element applied sciences,” stated Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing technology and further strengthens our sensor portfolio with new proprietary know-how. In addition to engaging biopharma applications, we expect strong growth within the semiconductor area on the capacity expansion and re-shoring tailwinds.”
Share